Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniele Marmolino

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Brain Research Reviews|May 10, 2011
Friedreich's ataxia: past, present and futureDaniele Marmolino
Current Opinion in Neurology|May 8, 2009
Cerebellar ataxiasMario Manto, Daniele Marmolino
Cerebellum (London, England)|August 12, 2009
Animal models of human cerebellar ataxias: a cornerstone for the therapies of the twenty-first centuryMario Manto, Daniele Marmolino
Cerebellum (London, England)|January 24, 2009
Friedreich's Ataxia: from the (GAA)n repeat mediated silencing to new promising molecules for therapyDaniele Marmolino, Fabio Acquaviva
Cerebellum (London, England)|December 24, 2008
PPAR-gamma agonist Azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich's ataxia therapyDaniele Marmolino, Fabio Acquaviva, Michele Pinelli, et al.
Plos One|April 13, 2010
PGC-1alpha down-regulation affects the antioxidant response in Friedreich's ataxiaDaniele Marmolino, Mario Manto, Fabio Acquaviva, et al.
Cerebellum (London, England)|June 27, 2008
Recombinant human erythropoietin increases frataxin protein expression without increasing mRNA expressionFabio Acquaviva, Imma Castaldo, Alessandro Filla, et al.
Human Molecular Genetics|April 21, 2009
Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich's ataxiaGiovanni Coppola, Daniele Marmolino, Daning Lu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Brain Research Reviews|May 10, 2011
Friedreich's ataxia: past, present and futureDaniele Marmolino
Current Opinion in Neurology|May 8, 2009
Cerebellar ataxiasMario Manto, Daniele Marmolino
Cerebellum (London, England)|August 12, 2009
Animal models of human cerebellar ataxias: a cornerstone for the therapies of the twenty-first centuryMario Manto, Daniele Marmolino
Cerebellum (London, England)|January 24, 2009
Friedreich's Ataxia: from the (GAA)n repeat mediated silencing to new promising molecules for therapyDaniele Marmolino, Fabio Acquaviva
Cerebellum (London, England)|December 24, 2008
PPAR-gamma agonist Azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich's ataxia therapyDaniele Marmolino, Fabio Acquaviva, Michele Pinelli, et al.
Plos One|April 13, 2010
PGC-1alpha down-regulation affects the antioxidant response in Friedreich's ataxiaDaniele Marmolino, Mario Manto, Fabio Acquaviva, et al.
Cerebellum (London, England)|June 27, 2008
Recombinant human erythropoietin increases frataxin protein expression without increasing mRNA expressionFabio Acquaviva, Imma Castaldo, Alessandro Filla, et al.
Human Molecular Genetics|April 21, 2009
Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich's ataxiaGiovanni Coppola, Daniele Marmolino, Daning Lu, et al.
Pageof 1